Short Summary
Microchip Technology initiated an IPR challenging the validity of Aptiv Technologies' patent 9460037, arguing that the claimed USB hub features are obvious. The petition focuses on combining prior art (Chang and Chang II) to demonstrate predictable design choices in computer networking hardware.
Detailed Summary
Microchip Technology filed a Petition for Inter Partes Review against U.S. Patent No. 9460037, owned by Aptiv Technologies AG et al., asserting that the claims are obvious under 35 U.S.C. § 103. The petitioner argues that combining existing components—specifically Chang and Chang II—to create a dual-role USB hub with routing capabilities was routine for a Person Having Ordinary Skill In The Art (POSITA). Key arguments revolve around the predictability of implementing features like host-to-host bridges and integrated digital routing logic within automotive connectivity systems.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Microchip Technology, Inc. vs Aptiv Technologies AG et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Amazon.com, Inc. et al.vsNokia Technologies Oy
Amazon successfully instituted an IPR against Nokia regarding video compression standards, arguing that MPEG-1 teaches or suggests the claimed quantization methods. The Board found a reasonable likelihood of success despite initial claim construction disputes over sequence vs. picture parameters.
Generac Power Systems, Inc. et al.vsChampion Power Equipment, Inc.
Generac and co‑petitioners filed a joint request asking the PTAB to keep their settlement agreement (Exhibit 1300) confidential and separate from the patent file, limiting disclosure under 35 U.S.C. §317(b).
Taiwan Semiconductor Manufacturing Company, Ltd.vsAdvanced Integrated Circuit Process LLC
TSMC has filed an IPR petition challenging nine claims of the ’779 patent, asserting anticipation and obviousness over multiple prior‑art references including Torii, Mise, Yu, Gilmer and Chen. The petition also argues that the Board should not deny institution under §§314(a) and 325(d).
Samsung Electronics Co., Ltd. et al.vsHannibal IP LLC
Samsung and Hannibal IP jointly filed a motion to terminate IPR2025-01190 and keep their settlement agreement confidential.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck has filed a Post‑Grant Review petition challenging Halozyme’s U.S. Patent 12,037,618 covering engineered PH20 hyaluronidase proteins. The petition argues the claims lack written description, are not enabled, and are obvious over prior patents and publications.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.